Straits Times Index
3,287.82 +21.87 (+0.67%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,974.92 +437.11 (+2.36%) FTSE 100
8,425.34 +43.99 (+0.52%) BTC-USD
62,947.78 +1,659.64 (+2.71%) CMC Crypto 200
1,307.41 -50.60 (-3.73%)
Asensus Surgical, Inc. (2TX.F)
| Previous close | 0.2282 |
| Open | 0.2296 |
| Bid | 0.2314 x N/A |
| Ask | 0.2564 x N/A |
| Day's range | 0.2296 - 0.2296 |
| 52-week range | 0.1830 - 0.5950 |
| Volume | |
| Avg. volume | 4,685 |
| Market cap | 66.798M |
| Beta (5Y monthly) | 1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2900 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.00 |
GlobeNewswireAsensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release 2024 first quarter financial and operating results after the market closes on Tuesday, May 14, 2024. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast. To listen t
GlobeNewswireAsensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
Second System to be Utilized by one of the Largest Private Hospital Systems in Japan RESEARCH TRIANGLE PARK, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced that Sendai Tokushukai Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. "We're happy that Sendai Tokushukai Hospital has initiated a lease on the Senh
- GlobeNewswire
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
KARL STORZ to provide up to $20 million in bridge financingRESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient, today announced that it has entered into a non-binding letter of intent (the “letter of intent”) with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company (“KARL STORZ”) to
